Quidel Corp QDEL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 11:18 AM EST
155.48quote price arrow down-5.81 (-3.60%)
Volume
485,453
52 week range
73.01 - 306.72

...

Loading . . .

KEY STATS

  • Open162.37
  • Day High162.37
  • Day Low149.50
  • Prev Close161.29
  • 52 Week High306.72
  • 52 Week High Date08/06/20
  • 52 Week Low73.01
  • 52 Week Low Date03/16/20
  • Market Cap6.58B
  • Shares Out42.32M
  • 10 Day Average Volume1.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • 1 Year % Change94.77

RATIOS/PROFITABILITY

  • EPS (TTM)18.59
  • P/E (TTM)8.37
  • Fwd P/E (NTM)4.19
  • EBITDA (MRQ)1.113B
  • ROE (MRQ)85.63%
  • Revenue (MRQ)1.662B
  • Gross Margin (MRQ)81.17%
  • Net Margin (MRQ)48.76%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories...
Kenneth Buechler Ph.D.
Chairman
Douglas Bryant
Chief Executive Officer
Robert Bujarski J.D.
Chief Operating Officer
Randall Steward
Chief Financial Officer
Address
9975 Summers Ridge Road
San Diego, CA
92121
United States